# A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis

> **NCT03277066** · PHASE2 · COMPLETED · sponsor: **Noven Pharmaceuticals, Inc.** · enrollment: 289 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** Diclofenac Sodium Active Topical Patch 1
- **DRUG:** Diclofenac Sodium Active Topical Patch 2
- **DRUG:** Placebo patch

## Key facts

- **NCT ID:** NCT03277066
- **Lead sponsor:** Noven Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-07
- **Primary completion:** 2019-09-25
- **Final completion:** 2019-09-25
- **Target enrollment:** 289 (ACTUAL)
- **Last updated:** 2021-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03277066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03277066, "A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03277066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*